Davion Healthcare PLC has taken a significant step in expanding its U.S. operations by announcing the proposed acquisition of the Independence Care homecare network. This move is expected to enhance Davion's presence in the healthcare market, particularly in the surgical and medical instruments sector.

On November 16, 2026, Davion Healthcare issued a press release detailing the agreement made by its wholly owned subsidiary, Davion Healthcare Corp. The acquisition involves 14 businesses across ten states, with an aggregate consideration of up to $10 million. This amount includes cash, company shares, and performance-related earnouts.

Company Background

Davion Healthcare PLC, traded on Nasdaq under the ticker DAVI, operates in the surgical and medical instruments and apparatus sector (SIC: 3841). The company is focused on building a diversified healthcare services group across North America and Europe. Recent filings indicate that Davion is an emerging growth company and a non-accelerated filer, with its fiscal year ending on December 31.

What the Filing Says

The filing states, "The proposed transaction remains subject to satisfactory due diligence, the negotiation and execution of definitive agreements, required regulatory approvals, and applicable closing conditions." This indicates that while the acquisition is planned, several steps must be completed before it can be finalized.

Impact

This acquisition could significantly impact Davion Healthcare's growth trajectory by establishing a multi-state homecare platform. The 14 businesses involved in the acquisition generated approximately $17 million in revenue in 2025, which demonstrates their established operations. This revenue will be accretive to Davion, potentially enhancing its financial performance.

What's Next

The filing does not specify what happens next, but it is clear that Davion will proceed with due diligence and negotiations to finalize the agreement. The company aims to strengthen its healthcare services and expand its operational footprint in the U.S. market.